BetterLife Pharma Inc. (FRA:NPAU)

Market Cap	15.78M +55.5%
Revenue (ttm)	n/a
Net Income	-1.19M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0675
Previous Close	0.0485
Day's Range	0.0675 - 0.0675
52-Week Range	0.0175 - 0.0675
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 2, 2026

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company offers a product pipeline that includes BETR-001, a non-hallucinogenic neuroplastogen based on 2-bromo-lysergic acid diethylamide (2-bromo-LSD), intended for the treatment of major depressive disord...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2002
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NPAU

Financial Performance

Financial numbers in CAD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error